Biomedical doctor faces allegations in Ireland over unapproved cancer treatment

Adas Darinskas, a biomedical sciences doctor currently facing trial in Vilnius for the illegal production of alprazolam, has attracted the attention of law enforcement in Ireland. In Ireland, he is accused of promoting an innovative cancer treatment to patients without proper authorization. The advertised treatment reportedly ranged in price from 30,000 to 50,000 euros.

Darinskas, who spoke with "Delfi," stated that all services were legally provided in Lithuania. He described the situation involving Ireland as "strange." The allegations in Ireland center on the unauthorized advertising of his cancer treatment, raising questions about cross-border medical practices and regulations.

While Darinskas is already under legal scrutiny in Lithuania for drug-related offenses, these new accusations in Ireland add another layer to his legal challenges. The specifics of the "innovative cancer treatment" and the nature of its promotion in Ireland remain subjects of further investigation.